RNS
XLRN

Robert N. Shapiro’s Acceleron Pharma XLRN Stock Holding History

Robert N. Shapiro’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$17K Buy
424
+317
+296% +$11K ﹤0.01% 638
2014
Q3 		$3K Hold
107
– – ﹤0.01% 815
2014
Q2 		$4K Buy
+107
New +$3.58K ﹤0.01% 712

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Robert N. Shapiro's XLRN Position: Q4 2014 in Review

Robert N. Shapiro increased its Acceleron Pharma (XLRN) stake by 296% in Q4 2014, buying an estimated $11K and bringing the position to 424 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #638.

Robert N. Shapiro first reported a position in XLRN in Q2 2014 and has held it in 3 quarters since. 110 funds tracked by Wall St. Rank hold XLRN as of Q4 2014.

  • Robert N. Shapiro held 424 shares of Acceleron Pharma worth $17K as of Q4 2014.
  • Robert N. Shapiro bought 317 Acceleron Pharma shares in Q4 2014, an estimated $11K.
  • Acceleron Pharma made up ﹤0.01% of Robert N. Shapiro's portfolio in Q4 2014, its #638 holding.
  • Robert N. Shapiro first reported a position in Acceleron Pharma in Q2 2014 and has held it in 3 quarters since.
  • 110 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.